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The Iowa Department of Public Health (IDPH) offers the Opioid Update to share information 
about opioid use and Iowa’s efforts to address the national opioid epidemic. Please feel free to 
submit topics to Julie Jones at julie.jones@idph.iowa.gov.  
 
In this issue:  
 
• Legislative Interest 
• Opioid News 
 
Legislative Interest 
 
Prescription Drug Monitoring Programs  
 
During the legislative session, IDPH will spotlight opioid-related initiatives or promising practices 
endorsed by federal partners and adopted by other states. In this edition, the focus is on 
Prescription Drug Monitoring Programs. 
 
According to the Centers for Disease Control and Prevention, prescription drug monitoring 
programs continue to be among the most promising state-level interventions to improve 
responsible opioid prescribing, inform clinical practice, and protect patients at risk.  
 
So what is a prescription drug monitoring program (PDMP), or, as it’s called in Iowa, a 
prescription monitoring program (PMP)?  A PDMP is an electronic database that tracks 
controlled substance prescriptions in a state. PDMPs can provide health authorities timely 
information about prescribing and patient behaviors that contribute to the epidemic and facilitate 
a nimble and targeted response. 
 
 
 
Although findings are mixed, evaluations of PDMPs have illustrated changes in prescribing 
behaviors, use of multiple providers by patients, and decreased substance abuse treatment 
admissions. States have implemented a range of ways to make PDMPs easier to use, and 
these changes have significant potential for ensuring that the utility and promise of PDMPs are 
realized.  
 
Some of the more promising PDMP features include: 
 
• Universal Use: PDMPs can inform health care providers about their patients’ prescription 
histories as they make prescribing decisions. However, a PDMP is only useful to health care 
providers if they check the system before prescribing. 
 
• Real-Time: When pharmacists dispense controlled substances to patients, they must enter 
the prescription into the state PDMP. However, when they submit this data varies greatly —
ranging from monthly to daily to “real-time,” i.e., under five minutes. When there is a long 
time period between dispensing a prescription and entering the data into the state PDMP, 
providers and other PDMP users don’t have information on a patient’s most recent 
prescriptions. 
 
• Actively Managed: PDMPs are more than passive databases. As a public health 
surveillance tool, PDMPs can be used by state health departments to understand the 
opioid use epidemic and inform and evaluate interventions. PDMPs can also be used to 
send “proactive” reports to authorized users to protect patients at the highest risk and 
identify inappropriate prescribing trends. 
 
• Easy to Use and Access: States have taken a number of steps to make PDMPs easier 
to use and access. Promising practices include integrating PDMPs into electronic health 
record (EHR) systems, permitting physicians to delegate PDMP access to other allied 
health professionals in their office (e.g., physician assistants and nurse practitioners), 
and streamlining the process for providers to register with the PDMP. 
There is a lot of activity in Iowa related to this topic. The Iowa Board of Pharmacy released an 
RFP for a new/upgraded PMP that will provide easier integration with provider EHRs. In 
addition, legislation has been introduced this session that would lead to more changes.  
Currently, Iowa Code does not require prescribers to use the PMP.  In fact, only 46% of Iowa 
prescribers are registered to use the PMP, with an even smaller percentage actually using it.  
The proposed legislation would require prescribers to register, and require use of the PMP in 
certain situations.  Other parts of the legislation require the upload of data to the PMP within 24 
hours and use of proactive reports.      
 
Opioid News 
 
How a Police Chief, a Governor and a Sociologist Would Spend $100 Billion to 
Solve the Opioid Crisis* 
 
In a recent New York Times article, 30 experts were asked, if given the opportunity, how would 
they spend $100 billion over five years, to address the opioid crisis. To read the entire article 
and see a breakdown of the responses, please click on the following link: NY Times  
 
New SAMHSA Publication: Clinical Guidance for Treating Pregnant and Parenting 
Women with Opioid Use Disorder and their Infants 
 
The new SAMHSA Clinical Guide provides comprehensive national guidance for optimal 
management of pregnant and parenting women with opioid use disorder and their infants. The 
Clinical Guide helps healthcare professionals and patients determine the most clinically 
appropriate action for a particular situation and informs individualized treatment decisions.   
 
To download a copy of the Clinical Guide, please click on the following link: SAMHSA 
